Physician profile
Beckie Michael
NPI 1346272796
$17,044.50
in general payments reported to CMS, 2019-2025
16 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $515 · 2021: $24.15 · 2022: $470 · 2023: $57.25 · 2024: $575 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120 · Education: $41.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.23 |
| Education | $41.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $9,618.55 | 2019-2020 | |
| Rockwell Medical, INC. | $3,356.86 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $2,113.66 | 2019-2023 | Lokelma |
| Calliditas Therapeutics US INC. | $366.32 | 2024-2025 | Tarpeyo |
| Vifor Pharma, INC. | $250.93 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $243.17 | 2022-2025 | |
| Ardelyx, INC. | $234.30 | 2024-2025 | Xphozah 30 Mg |
| Otsuka America Pharmaceutical, INC. | $230.59 | 2019-2022 | |
| Medtronic, INC. | $155.64 | 2025 | Ellipsys Vascular Access System |
| Baxter Healthcare | $117.76 | 2024 | |
| Glaxosmithkline, LLC. | $108.58 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $106.06 | 2019 | |
| Mozarc Medical US LLC | $75.00 | 2024 | Argyle |
| Akebia Therapeutics INC | $39.35 | 2020-2024 | Vafseo |
| Travere Therapeutics, INC. | $16.89 | 2025 | Filspari |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beckie Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.